Article

The design and synthesis of a new lead against tuberculosis

2008-01-01

Abstract excerpt

It is estimated that one-third of the world's population has been exposed to the tuberculosis bacterium; killing eight million every year. Since the 1960s there have been no new drugs marketed, which is primarily due to the Mycobacterium tuberculosis bacilli having a complex cell wall structure, intracellular existence in the host and its ability to stay dormant for extended periods. The continual increase in drug...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 74e22d05-108e-5dea-8af2-2ab115c8bcc0
DOI: 10.48730/xhja-kv32

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The design and synthesis of a new lead against tuberculosisDOI 10.48730/xhja-kv32Read

New structural classes of antituberculosis agentsSemantic proximity Read

Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents.Semantic proximity Read

Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screeningSemantic proximity Read

Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosisSemantic proximity Read

NSC19723, a Thiacetazone-Like Benzaldehyde Thiosemicarbazone Improves the Efficacy of TB Drugs In Vitro and In VivoSemantic proximity Read

Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.Semantic proximity Read

Exploring natural products library to identify potential inhibitors targeting isoniazid-resistant tuberculosis.Semantic proximity Read

Identification and Validation of Novel Drug Targets in TuberculosisSemantic proximity Read

Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3.Semantic proximity Read

Pipeline of anti‐Mycobacterium abscessussmall molecules: Repurposable drugs and promising novel chemical entitiesSemantic proximity Read

Exploration of potential inhibitors for tuberculosis via structure‐based drug design, molecular docking, and molecular dynamics simulation studiesSemantic proximity Read

Side Chain-modified Benzothiazinone Derivatives with Anti-Mycobacterial ActivitySemantic proximity Read